Home
Approach
Our Values
Research
How We Work
Pedagogy
Research
Health Equity
Health Capability
Health Efficiency
Resource Allocation
Health Financing
Health Governance
Theories
Collaboration
People
Collaborators
Research Network
Funding
Publications
News
Health Equity & Policy Lab
Home
Approach
Our Values
Research
How We Work
Pedagogy
Research
Health Equity
Health Capability
Health Efficiency
Resource Allocation
Health Financing
Health Governance
Theories
Collaboration
People
Collaborators
Research Network
Funding
Publications
News
Health Efficiency
Micro-Costing
Micro-Costing Checklist
Micro-Costing Critical Appraisal
Application: Costs of Addiction Treatment
How can microcosting be used to evaluate smoking cessation and relapse prevention interventions?
How can we use microcosting in policy making for HIV Interventions?
What are the costs of treatment for heroin addiction in 33 countries worldwide?
Is it costly to target pregnant women with substance use and HIV prevention programs?
Economic Evaluation
Economic Evaluation of Substance Abuse and HIV/AIDS Prevention for Women
Smoking Cessation and Relapse Prevention
Economic Evaluations of Smoking Cessation and Relapse Prevention
Motivational Interviewing for Smoking Cessation
Micro-Costing Methodology
Cost Effective of Pharmaco and Behavioral therapies for Smoking Cessation
Drug Abuse Treatment and Prevention of Other Risky Behavior
Substance Abuse Interventions
Are peer-delivered interventions for cocaine and alcohol abuse among women cost-effective?
Most Cost-Effective Intervention to Prevent HIV/AIDS and STDs among Women
Cost Effective Treatments for Heroin Dependence
Drug Abuse and HIV Prevention Programs
Substance Use In Pregnant Women
How does pregnancy intervention impact substance use abstinence
Postpartum Contraception
Behavioral Intervention for Substance Use Treatment
ECONOMIC EVALUATION OF ADDICTION TREATMENT AND RISKY BEHAVIOR PREVENTION
ECONOMIC EVALUATION OF SUBSTANCE ABUSE TREATMENT AND HIV/AIDS PREVENTION FOR WOMEN
SMOKING CESSATION AND RELAPSE PREVENTION
ALCOHOL, COCAINE, MARIJUANA, OPIOID, HERION, HALLUCINOGENS, AMPHETAMINE ABUSE TREATMENT AND PREVENTION OF OTHER RISKY BEHAVIORS
BACK TO HEALTH EFFICIENCY
